Professional Documents
Culture Documents
Physicians and past LDLT recipients, many with their families, were at an event at Abu Dhabi
today to mark the collaboration between both sides over the last 15 years. AALC, based in
Gleneagles Hospital, is led by renowned liver surgeon Dato Dr Tan Kai Chah. AALC is one of
Asias leading liver centres that offer the LDLT programme in a private hospital. To date,
AALC has carried out 244 LDLTs 22% of them involving UAE nationals.
The LDLT programme offers Emiratis with end-stage liver disease the option to seek
specialised treatment in Singapore. From pre-surgery to post-operative care, AALC works
closely with UAE physicians to ensure that all patients have a smooth treatment journey.
LDLT is one of the most important innovations in liver treatment. As incidences of liver
disease continue to rise, LDLT provides an alternative life-saving therapy for many patients
who would otherwise die while waiting for a cadaveric organ. As long as the cadaveric donor
shortage remains acute in the UAE, LDLTs will remain an important life-saving option for
patients.
We deeply appreciate that, for over a decade, Emiratis from all walks of life have entrusted
AALC with their liver health. Together, we have saved the lives of over 55 patients. Looking
ahead, we expect to accomplish much more, said Dr Tan, who is also Executive Chairman of
Asian American Medical Group (AAMG), which is listed on the Australian Securities
Exchange.
During the event, Mr Anthony Lim - Head of International Marketing, from Parkway Hospital
Singapore, shared highlights of the cross-border LDLT Programme for Emiratis. This includes
the Parkway Asian Transplant Unit (PATU), a dedicated transplant unit which is jointly
managed by AALC with integrated intensive care unit facilities.
Patients from the UAE can be assured that Gleneagles Hospital, Singapore, will provide
them with cutting-edge medical technology and facilities. A perfect example of this is the
PATU ward which has enabled our surgeons to consistently deliver excellent clinical
outcomes and seamless patient care, said Mr Lim.
1
About Asian American Liver Centre
Since 1994, Asian American Liver Centre (AALC), formerly known as Asian Centre for Liver Diseases and
Transplantation Pte Ltd, is one of Asias foremost and largest private liver centres for the treatment of liver,
pancreas and bile duct diseases in adults and children. It is a wholly owned subsidiary of the Australian Stock
Exchange-listed Asian American Medical Group.
Led by Dato Dr Tan Kai Chah, together with a multidisciplinary team, AALC's dedicated outpatient and
inpatient facilities offer a comprehensive suite of services for both its local and international patients and
ensures that patients receive the best possible treatment and care.
AALC has performed 244 living donor living transplantation procedures to-date, with consistently good clinical
outcomes. It is one of the largest private liver centres in Southeast Asia. Given its vast experience and a highly
successful living donor living transplantation programme, AALC has remained an important referral centre for
the treatment of acute liver failure and liver transplants.
Media Enquiries
WeR1 Consultants
Tel: +65 6737 4844
(Singapore) Ms Rachael De Foe; rachaeldefoe@wer1.net
(Malaysia) Ms Sophia Halim; sophiahalim@wer1.net
PATU, which consists of 7 Intensive Care Units (ICU) and 12 patient rooms, is specially designed to provide
personalised and comprehensive medical care for HPB and transplant patients. Fully equipped with
sophisticated medical equipment, including various types of liver dialysis machines, monitoring devices and
ventilators, it supports seamless patient care between the ICU and the general ward, and enables our team of
specialised surgeons, doctors and nurses to guide patient and their families through the entire process from
surgery to post-transplant monitoring and recovery. The medical and nursing teams are specially trained to
care for such patients, including both adults and children.